Edition:
United States

Biospecifics Technologies Corp (BSTC.OQ)

BSTC.OQ on NASDAQ Stock Exchange Global Market

61.10USD
17 Oct 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$61.10
Open
$61.47
Day's High
$61.47
Day's Low
$61.10
Volume
4,492
Avg. Vol
11,072
52-wk High
$62.45
52-wk Low
$38.12

Latest Key Developments (Source: Significant Developments)

Biospecifics Technologies reports Q3 eps of $0.37
Friday, 10 Nov 2017 08:06am EST 

Nov 10 (Reuters) - Biospecifics Technologies Corp ::Biospecifics Technologies Corp reports Q3 2017 financial results.Q3 revenue $6.5 million versus $6.9 million.Q3 earnings per share $0.37.As of september 30, 2017, co had cash & cash equivalents & investments of $61.3 million.  Full Article

BioSpecifics Technologies reports Q2 earnings per share $0.36
Wednesday, 9 Aug 2017 04:01pm EDT 

Aug 10 (Reuters) - BioSpecifics Technologies Corp -:BioSpecifics Technologies Corp reports second quarter 2017 financial results.Q2 earnings per share $0.36.Q2 revenue rose 18 percent to $50.1 million.BioSpecifics Technologies Corp - endo continues to anticipate high-single to low-double digit revenue growth for sales of xiaflex in 2017.  Full Article

Biospecifics Technologies reports Q1 earnings per share $0.46
Wednesday, 10 May 2017 04:05pm EDT 

May 10 (Reuters) - Biospecifics Technologies Corp :Biospecifics Technologies Corp. reports first quarter 2017 financial results.Q1 earnings per share $0.46.Says total revenue for Q1 ended March 31, 2017 was $7.7 million, compared to $6.6 million for same period in 2016.  Full Article

Biospecifics Technologies Q4 earnings per share $0.40
Wednesday, 15 Mar 2017 08:00am EDT 

Biospecifics Technologies Corp : Biospecifics Technologies Corp reports fourth quarter and full year 2016 financial results . Q4 earnings per share $0.40 .Biospecifics Technologies Corp says total revenue for q4 ended december 31, 2016 was $6.6 million, compared to $6.1 million for same period in 2015.  Full Article

BRIEF-Biospecifics Technologies Reports Q1 Earnings Per Share $0.54

* BIOSPECIFICS TECHNOLOGIES CORP. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS